Literature DB >> 237331

Nitrogen sparing by carbohydrate in man: Intermittent or continuous enteral compared with continuous parenteral glucose.

G F Fitzpatrick, M M Meguid, R C O'Connell, N E O'Connor, M R Ball, M F Brennan.   

Abstract

To test whether oral carbohydrate would provide greater conservation of body protein than would intravenous carbohydrate, healthy normal human subjects were infused with high doses of glucose either continuously intravenously or by nasogastric tube in both continuous and intermittent regimes. Metabolic responses to high calorie, nitrogen-free infusions in normal man were documented in the blood hormone and substrate changes, and protein sparing was assessed by urinary nitrogen excretion. Continuous glucose produced a lower urinary "nitrogen floor" than did the intermittent regime, and intravenous glucose was more effective than was oral glucose. The insulin responses to continuous nasogastric and continuous intravenous glucose were similar, and nitrogen excretion did not differ between those two groups. The increased insulin levels seen with intermittent glucose were not accompanied by greater protein sparing.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 237331

Source DB:  PubMed          Journal:  Surgery        ISSN: 0039-6060            Impact factor:   3.982


  3 in total

1.  Substrate interaction in intravenous feeding: comparative effects of carbohydrate and fat on amino acid utilization in fasting man.

Authors:  B M Wolfe; J M Culebras; A J Sim; M R Ball; F D Moore
Journal:  Ann Surg       Date:  1977-10       Impact factor: 12.969

2.  Intravenous amino acids as the sole nutritional substrate. Utilization and metabolism in fasting normal human subjects.

Authors:  D E Tweedle; G F Fitzpatrick; M F Brennan; J M Culebras; B M Wolfe; M R Ball; F D Moore
Journal:  Ann Surg       Date:  1977-07       Impact factor: 12.969

3.  Effect of glucose, independent of changes in insulin and glucagon secretion, on alanine metabolism in the conscious dog.

Authors:  G I Shulman; W W Lacy; J E Liljenquist; U Keller; P E Williams; A D Cherrington
Journal:  J Clin Invest       Date:  1980-02       Impact factor: 14.808

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.